Falcon Bio Overview

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

Falcon Bio General Information

Description

Developer of therapeutic treatments intended to address cellular dysfunction in patients with Friedreich's ataxia. The company's technology utilizes genetic suppression to restore iron-sulfur cluster production and mitochondrial function, providing healthcare providers with novel therapies for rare genetic diseases.

Contact Information

Website
www.falcon.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 200 Clarendon Street
  • 22nd Floor
  • Boston, MA 02116
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 200 Clarendon Street
  • 22nd Floor
  • Boston, MA 02116
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Falcon Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Aug-2026 Completed Startup
To view Falcon Bio’s complete valuation and funding history, request access »

Falcon Bio Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Falcon Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026198818-A2 Small interfering rna compounds for targeting ferredoxin 2 (fdx2) and method of treating friedreich ataxia (frda) Pending 19-Mar-2025
WO-2026198818-A3 Small interfering rna compounds for targeting ferredoxin 2 (fdx2) and method of treating friedreich ataxia (frda) Pending 19-Mar-2025
WO-2026107101-A2 Compounds for targeting ferredoxin 2 (fdx2) in friedreich ataxia (frda) Pending 13-Nov-2024
WO-2026107101-A3 Compounds for targeting ferredoxin 2 (fdx2) in friedreich ataxia (frda) Pending 13-Nov-2024 A61K31/7125

Falcon Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mass General Brigham Ventures Venture Capital Minority
To view Falcon Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

Falcon Bio FAQs

  • Where is Falcon Bio headquartered?

    Falcon Bio is headquartered in Boston, MA.

  • What industry is Falcon Bio in?

    Falcon Bio’s primary industry is Drug Discovery.

  • Is Falcon Bio a private or public company?

    Falcon Bio is a Private company.

  • What is Falcon Bio’s current revenue?

    The current revenue for Falcon Bio is .

  • Who are Falcon Bio’s investors?

    Mass General Brigham Ventures has invested in Falcon Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process